Taige Pharmaceuticals: wholly owned subsidiary acquires 56.37% equity of Japanese company MICRON

Tiger Pharmaceuticals announced on July 29th that its wholly-owned subsidiary Tiger Pharmaceuticals Japan has signed a "Share Transfer Agreement" with the original shareholders of Japanese company MICRON Co., Ltd., purchasing their 56.37% stake for a total purchase price of 484 million Japanese yen, equivalent to 23.4771 million RMB. After this transfer is completed, Tiger Pharmaceuticals Japan will hold a 56.37% stake in MICRON. With the completion of this transaction, leveraging MICRON's strong foundation and customer resources in the Japanese market, it will be beneficial for the company to further expand its business in Japan and the Asia-Pacific region; at the same time, both parties can achieve a deep integration of technology and talent, enhance comprehensive competitiveness in the fields of medical imaging and clinical services, and have a positive impact on the company's future operations, benefiting all shareholders of the company.